The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127614301 12761430 1 I 20160912 20160920 20160920 EXP US-ROCHE-1832113 ROCHE SHAH A, CHEN J AND FRIDELL J INCIDENCE AND OUTCOMES OF CYTOMEGALOVIRUS IN PANCREAS TRANSPLANTATION WITH STEROID-FREE IMMUNOSUPPRESSION. CLINICAL TRANSPLANTION 2015;29 (12):1221-1229. 0.00 F Y 0.00000 20160920 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127614301 12761430 1 PS GANCICLOVIR. GANCICLOVIR 1 Intravenous (not otherwise specified) U 19661 POWDER FOR INFUSION
127614301 12761430 2 SS VALGANCICLOVIR. VALGANCICLOVIR 1 Oral 450-900 MG U 22257 ORAL SOLUTION QD
127614301 12761430 3 SS VALGANCICLOVIR. VALGANCICLOVIR 1 Oral U 22257 ORAL SOLUTION
127614301 12761430 4 C ANTI-THYMOCYTE GLOBULIN (RABBIT) NOS LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN 1 Unknown 0
127614301 12761430 5 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 0
127614301 12761430 6 C TACROLIMUS. TACROLIMUS 1 0
127614301 12761430 7 C SIROLIMUS. SIROLIMUS 1 0
127614301 12761430 8 C BASILIXIMAB BASILIXIMAB 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127614301 12761430 1 Cytomegalovirus infection
127614301 12761430 2 Cytomegalovirus infection

Outcome of event

Event ID CASEID OUTC COD
127614301 12761430 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127614301 12761430 Cytomegalovirus colitis
127614301 12761430 Cytomegalovirus infection
127614301 12761430 Cytomegalovirus viraemia
127614301 12761430 Drug resistance

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found